Withdrawn HIV stigma study aimed to help young gay men in ghana slums
NCT ID NCT06312514
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study planned to test a program called Lafiya (meaning 'Wellness') designed to reduce stigma and discrimination faced by young gay, bisexual, and other men who have sex with men living in Ghanaian slums. The goal was to see if the program could increase HIV testing, use of PrEP (a daily pill to prevent HIV), and adherence to HIV treatment. However, the study was withdrawn before any participants were enrolled, so no data was collected.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- LAFIYA behavioral intervention
- What this could lead to
- If successful, this program could point toward effective ways to reduce stigma and increase HIV testing and prevention in marginalized communities.
- What could go wrong
- The study was withdrawn before enrolling any participants, so no results are available. It was a small feasibility trial, so even if conducted, findings might not apply broadly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Ghana
Accra, Ghana
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new strategy break the cycle of HIV care dropout?
- A One-Two punch against cervical cancer: testing plus vaccination in HIV-Positive women
- Can a smartphone app curb HIV risk in south Korea's young gay men?
- Smart pill bottles and health coaches team up to tackle HIV in the deep south
- Can one Mega-Dose of an antifungal beat a deadly infection in AIDS patients?
- Can Long-Acting HIV shots outperform daily pills during lymphoma treatment?